Joint Pain Injections Market Expected to Reach $13,176.31 million by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Joint Pain Injections Market," The joint pain injections market size was valued at $6,271.91 million in 2021, and is projected to reach $13,176.31 million by 2031, growing at a CAGR of 7.7% from 2022 to 2031.

Injections for joint pain are usually given directly into the joint to reduce swelling and irritation thereby reducing pain. Due to pre-existing diseases or conditions, joint pain affects the elderly population more frequently than the general population. Joint discomfort may be worsened by musculoskeletal diseases that produce pain and inflammation, such as arthritis and sacroiliac joint pain. The drugs are basically delivered to the painful joint inside the joint capsule. Joint pain injections are used to treat pain caused due to the various reasons including the arthritis and its different kinds, the previous injuries to a joint, overuse of the muscle, depression, anxiety, stress, and obesity

According to the WHO, World Health Organization, there are between 20 and 50 million people every year who suffer non-fatal injuries, with many incurring a disability as a result of their injury. Post-traumatic arthritis is caused due the injuries, and leading to the rise in the number of the arthritis cases. Thus, the rise in these cases around the globe, due to the rise in the number of the accidents, leads to the increase in demand for the joint pain injection and thus lead to the growth of the joint pain injections market size.

In addition, rise in incidence of arthritis among all age groups owing to a sedentary lifestyle, rise in obesity, injuries due to physical activities and stress, along with the introduction of numerous cutting-edge treatment technologies by the pharmaceutical companies, an increase in the demand for accurate treatment options by the patients, and the availability of high income in the developed economies will lead to the sales of the joint pain injection on a large scale.

Furthermore, rise in the sales of hyaluronic acid injections creates lucrative opportunities for the market players, and the increase in the prevalence of knee & ankle injuries and knee-related disorders and rise in preference for viscosupplementation will accelerate the growth of the joint pain injections market share during the forecast period.

In joint pain injections market analysis injection type, others segment was the largest segment in the 2021 whereas the hyaluronic acid injections segment is expected to grow at a highest CAGR during the forecast period, due to increase in the number of joint related disorders and the rise in awareness about the usage of hyaluronic acid and its derivatives as the joint pain treatment option.

By joint type, the knee and ankle segment holds a dominant position in the global joint pain injections industry in 2021 owing to the high prevalence of the knee osteoarthritis cases, which when untreated is responsible for bone degeneration and further requires bone replacement surgery. On the other hand, the hip joint segment is expected to grow at the fastest rate CAGR during the forecast period due to the rise in joint pain injections market trends, such as increasing cases of avascular necrosis, which slows down the blood flow to the hip bone and causes hip joint pain.

By distribution channel, the drug stores and retail pharmacies owned the largest joint pain injections market share in 2021, because of the adoption of the advance treatment options related to the joint pain in hospitals and also due to easy availability of the injections in the nearest pharmacy. On the other hand, the online providers are expected to grow at the highest CAGR during the joint pain injections market forecast period.

Region wise, North America acquired a major share of the joint pain injections industry in the year 2021, owing to the presence of key players and manufacturers of joint pain injections that have been concentrating on creating innovative and effective treatment options in this region. However, Asia-Pacific is expected to witness the highest CAGR for the joint pain injections market throughout the forecast period due to the presence of a large patient pool, increase in treatment options, surge in geriatric population, and rise in awareness about joint-related disorders in India and China.

KEY FINDINGS OF THE STUDY

• By injection type, the others segment was the highest contributor to the market in 2021 and the hyaluronic acid injections segment is expected to grow at the fastest CAGR during the forecast period.
• By joint type, the knee and ankle joint segment was the highest contributor to the market in 2021, and the hip joint segment is expected to grow at the fastest rate during the forecast period.
• Depending on distribution channel, the drug store and retail pharmacies segment was highest contributor in 2021 and the online providers segment is expected to grow at the fastest CAGR during the forecast period.
• Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.